Frontlight ResearchEarly access
Trial site
Ganzhou Cancer Hospital
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Not yet recruiting4 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Sun Yat-sen University2 trials
- 3D Medicines (Sichuan) Co., Ltd.1 trial
- Antengene Biologics Limited1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- GeneQuantum Healthcare (Suzhou) Co., Ltd.1 trial
- and 2 more
Running trials
Recruiting
Not yet recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Recruiting
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL
Recruiting
Active, not recruiting
Recruiting
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026